Pearl Pathways

What Pearl Pathways does

Pearl Pathways is a life sciences professional services company that provides clinical, regulatory, and quality compliance support to biopharmaceutical, medical device, and diagnostic companies. The firm is organized around four integrated service modules: Regulatory Guidance and Global Filings, Quality Strategy Services (validation, auditing, training, remediation), Data and Project Management, and Medical Writing and Protocol Management. Delivery follows a partnership model in which Pearl Pathways' experienced team integrates directly with clients' clinical, regulatory, quality, and leadership functions to accelerate product development timelines. The firm is headquartered in Indianapolis, Indiana, and was founded in 2010.

Since 2023, Pearl Pathways has operated as a brand subsidiary of Versiti Clinical Trial Services, a 501(c)(3) nonprofit organization. Its standalone website was retired and operations migrated to a unified Versiti Clinical Trial Services platform, alongside sister brands Pearl IRB, Salus IRB, Cenetron, and Quantigen. Through this integration, Pearl Pathways gains access to broader capabilities including central laboratory services, biologistics, collection kits, IRB services, and specialty research products (leukapheresis, prospective blood collections), as well as expertise across benign hematology, transfusion medicine, oncology, immunology, cell and gene therapy, orphan and rare disease, in-vitro diagnostics, and HLA.

The business model is professional services revenue generated through custom consulting engagements, with quote-based pricing structured as multi-year contracts. Go-to-market is consultative and enterprise-focused, engaging senior leadership at life sciences sponsors through direct outreach. Headcount is reported as 11-50 employees. No funding rounds, M&A, or revenue disclosures are present in the source data.

Name

Pearl Pathways

Legal name

Pearl Pathways

Website

https://pearlpathways.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Pearl Pathways is a life sciences professional services firm providing clinical, regulatory, and quality compliance support to biopharmaceutical, medical device, and diagnostic companies. It operates as a subsidiary brand of Versiti Clinical Trial Services, a 501(c)(3) nonprofit, since 2023.

Ownership category

akta.pro rank

Product category

Life Sciences Regulatory & Clinical Consulting

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)

Keywords

• Regulatory affairs consulting
• Clinical trial services
• Quality compliance auditing
• Medical device regulatory
• Biopharmaceutical consulting

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Professional Services: Consulting and professional services revenue generated through partnerships with life sciences companies requiring clinical trial support, regulatory guidance, quality compliance, and auditing services. Services are customized to client needs, suggesting project-based or retainer fee arrangements.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Pearl Pathways is a comprehensive life sciences professional services company whose experienced team partners with biopharmaceutical, medical device, and diagnostic clients to provide clinical, regulatory, and quality compliance support. Service modules include Regulatory Guidance & Global Filings, Quality Strategy Services, Data & Project Management, and Medical Writing & Protocol Management. Since 2023, these capabilities have been delivered under the Versiti Clinical Trial Services platform.

Product overview

Pearl Pathways is a comprehensive life sciences professional services company and part of Versiti Clinical Trial Services (since 2023). The offering is a platform of integrated service modules including Regulatory Guidance & Global Filings, Quality Strategy Services, Data & Project Management, and Medical Writing & Protocol Management. These services work together to support biopharmaceutical, medical device, and diagnostic companies with clinical, regulatory, and quality compliance needs to accelerate bringing life saving therapeutics, devices, and diagnostics to market.

Differentiator

Problem solved

Functional benefit

Products and services

• Pearl Pathways Life Sciences Professional Services Comprehensive life sciences professional services offering for biopharmaceutical, medical device, diagnostic, and life sciences service provider clients, delivered as integrated clinical, regulatory, and quality compliance support.
• Regulatory Guidance & Global Filings Expert regulatory strategy and global filing support to accelerate approvals, reduce costs, and ensure compliance worldwide for life sciences clients.
• Quality Strategy Services Validation, auditing, training, and remediation services for clinical research ensuring regulatory readiness and GxP compliance.
• Data & Project Management Dedicated project and data management teams supporting clinical trials from start to finish.
• Medical Writing & Protocol Management Protocol writing, management, and reporting services ensuring compliance, accuracy, and efficiency in clinical trial processes.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Versiti Clinical Trial ServicescoreStrategic or Co-development Partner · 1 January 2023Pearl Pathways has been part of Versiti Clinical Trials since 2023 as a subsidiary brand. The company operates under the Versiti Clinical Trial Services umbrella, integrating its clinical, regulatory, and quality compliance expertise with Versiti's broader capabilities including central laboratory services, biologistics, collection kits, and IRB services. The transition consolidates Quantigen and Pearl Pathways websites into the unified Versiti Clinical Trial Services platform.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Syneos Health: Full-service CRO offering clinical solutions and regulatory consulting. Closely aligned with Pearl Pathways' clinical operations, regulatory, and quality service modules.
• Medpace: Mid-size full-service CRO focused on clinical trial management and regulatory support for biopharma and medical device sponsors. Direct peer in scale and clinical/regulatory service orientation.
• WuXi AppTec: Global CRO/CDMO providing clinical, regulatory, and laboratory services. Comparable in serving biopharma and diagnostics with cross-functional regulatory and clinical expertise.

Broad incumbents

• IQVIA: Global leader in clinical research, regulatory, and technology services for life sciences. Comparable as a broad incumbent offering the full clinical-regulatory-quality stack that Pearl Pathways covers at a much smaller scale.
• Labcorp Drug Development (Fortrea): Major CRO providing clinical trial management, central lab, and regulatory services. Directly comparable in service mix (clinical operations, regulatory filings, central lab) to the Pearl Pathways + Versiti offering.
• ICON plc: Global CRO offering clinical operations, regulatory affairs, and laboratory services across biopharma and medical devices. Comparable to Pearl Pathways' clinical-regulatory-quality service portfolio.
• Parexel International: Large CRO with deep regulatory consulting, clinical trial management, and quality compliance offerings. Closely mirrors Pearl Pathways' modular services across pharma, devices, and diagnostics.
• Charles River Laboratories: Life sciences research and CRO services spanning preclinical, clinical, and manufacturing support. Comparable in providing professional services to therapeutics and diagnostics developers.

Others

• Pearl IRB: Sister brand under Versiti providing accredited IRB services. Operates adjacent to Pearl Pathways' regulatory/quality practice and often bundled in the same client engagements.
• Cenetron: Sister brand under Versiti Clinical Trial Services providing central laboratory and biorepository services. Directly comparable as a peer within the same parent ecosystem serving overlapping diagnostic and pharma clients.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pearl Pathways